Investing U.S. FDA declines to approve expanded use of Acadia’s antipsychotic drug Post Content Continue Reading Previous: Jack Dorsey-led Block posts $1.5B in Q2 profits, BTC revenue downNext: Rio Tinto attracts several proposals to build 4 GW of wind, solar power Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.